Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:49 pm Unchanged |
2024-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 5,096,251 11.430% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:46 pm Purchase |
2024-09-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 5,096,251 10.820% |
470,061 (+10.16%) |
Filing History |
| 2024-02-14 2:21 pm Purchase |
2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 4,626,190 9.990% |
1,629,079 (+54.35%) |
Filing History |
| 2024-02-13 8:02 pm Sale |
2023-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Lind Global Fund II LP | 0 0.000% |
-3,000,000 (Position Closed) |
Filing History |
| 2023-03-20 4:35 pm Purchase |
2023-03-16 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Lind Global Fund II LP | 3,000,000 8.300% |
3,000,000 (New Position) |
Filing History |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-10 10:25 am Unchanged |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 3.400% |
0 (Unchanged) |
Filing History |
| 2022-12-19 06:05 am Purchase |
2022-12-08 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Cystic Fibrosis Foundation | 5,168,732 19.900% |
5,168,732 (New Position) |
Filing History |
| 2022-02-14 2:09 pm Sale |
2021-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Francis Capital Management LLC | 142,838 1.000% |
-534,021 (-78.90%) |
Filing History |
| 2021-07-27 1:20 pm Purchase |
2021-07-20 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 7.300% |
884,956 (New Position) |
Filing History |
| 2021-04-01 4:50 pm Purchase |
2021-03-17 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Francis Capital Management LLC | 676,859 6.100% |
676,859 (New Position) |
Filing History |